Justin D. Gover's Net Worth

$12.1 Million

Estimate Recalculated Sep 8, 2024 07:32PM EST

Who is Justin D. Gover?

Justin D. Gover has an estimated net worth of $12.1 Million. This is based on reported shares across multiple companies, which include GW PHARMACEUTICALS PLC, and Xenon Pharmaceuticals Inc..

SEC CIK

Justin D. Gover's CIK is 0001754129

Past Insider Trading and Trends

2020 was Justin D. Gover's most active year for acquiring shares with 15 total transactions. Justin D. Gover's most active month to acquire stocks was the month of February. 2020 was Justin D. Gover's most active year for disposing of shares, totalling 28 transactions. Justin D. Gover's most active month to dispose stocks was the month of April. 2021 saw Justin D. Gover paying a total of $616.11 for 1,295,436 shares, this is the most they've acquired in one year. In 2021 Justin D. Gover cashed out on 3,173,777 shares for a total of $3,889,392.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GW PHARMACEUTICALS PLC No price found

Chief Executive Officer

Justin D. Gover used to own units in Ordinary Shares but no longer holds any shares there. In the year 2018 Justin D. Gover filed a total of 23 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.55M
—
—
0
May 5
Form 4
-12.88%
-276.00K
—
—
1.87M
Mar 19
Form 4
—
0
—
—
0
Mar 2
Form 4
+4,455,360.00%
222.77K
$17.90
-$3,888,776.49
222.77K
Feb 26 - Mar 1
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
456.05K
Dec 31
Form 4
—
0
$10.02
-$1,086,946.04
456.05K
Scheduled
Nov 13 - Nov 17
Form 4
—
0
$10.01
-$715,630.12
456.05K
Scheduled
Nov 9 - Nov 12
Form 4
+0.46%
2.09K
$10.23
-$21,232.07
456.05K
Jun 15
Form 4
—
0
—
—
0
Jun 4
Form 4
+2.72%
14.99K
$8.33
-$273,727.16
566.51K
Mar 2
Form 4
-2.13%
-12.00K
$9.05
-$108,558.24
551.52K
Feb 26
Form 4
—
0
$9.62
-$1,944,415.35
563.52K
Scheduled
Feb 3
Form 4
+0.95%
5.33K
$9.17
-$48,953.93
563.52K
Scheduled
Dec 17
Form 4
+3.08%
16.66K
—
$21.65
558.2K
Jun 14
Form 4
—
0
$15.24
-$3,081,541.59
541.54K
Scheduled
May 28
Form 4
+4.72%
24.43K
$14.01
-$328,035.51
541.54K
Scheduled
Mar 15
Form 4
—
0
—
—
0
Mar 1
Form 4
+3.06%
11.33K
$12.45
-$138,298.91
381.77K
Feb 26
Form 4
-5.75%
-22.62K
$12.50
-$282,750.00
370.44K
Scheduled
Feb 13
Form 4
-5.44%
-22.62K
$8.33
-$188,406.60
393.06K
Jan 2
Form 4
+12.21%
45.24K
—
$58.81
415.69K
Dec 20
Form 3
—
0
—
—
0
No matching records found

Xenon Pharmaceuticals Inc. (XENE) Snapshot price: $38.47

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Aug 10
Form 3
—
0
—
—
0
No matching records found